Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
1381432
Title:
HSA-VRIJE SAMENSTELLINGEN VAN INTERFERON-BETA
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic information
Application number:
019884667
WO application number:
US2001051074
Type:
European patent granted for BE
Status:
Expired
Publication number:
1381432
WO publication number:
WO 2002/080976
1rst applicant's nationality:
Translation language:
Dutch
EPO publication language:
English
SPC number:
2012C/038
Dates
Filing date:
26/10/2001
Grant date:
15/02/2012
EP publication date:
WO publication date:
Claims translation received date:
05/08/2011
Translation received date (EP publication B1):
15/02/2012
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
05/08/2011
EP B1 publication date:
15/02/2012
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
26/10/2021
Applicant
1
Name:
GlaxoSmithKline Biologicals S.A.
Legal Form:
From:
15/02/2018
Address:
rue de l'Institut 89, 1330 Rixensart, Belgium (BE)
To:
2
Name:
Novartis Vaccines and Diagnostics, Inc.
Legal Form:
From:
15/02/2012
Address:
4560 Horton Street, Emeryville CA 94608, United States (US)
To:
06/12/2017
3
Name:
Novartis Vaccines and Diagnostics, Inc.
Legal Form:
From:
06/12/2017
Address:
2711 Centerville Road, Suite 400, Wilmington, DE 19808, United States (US)
To:
06/12/2017
4
Name:
GlaxoSmithKline Biologicals s.a.
Legal Form:
From:
06/12/2017
Address:
rue de l'Institut 89, 1330 Rixensart, Belgium (BE)
To:
15/02/2018
Agent
Name:
BRAS Piet
Legal Form:
From:
20/02/2012
Address:
Koninginnegracht 19, 2514 AB, DEN HAAG, Netherlands (NL)
To:
Inventor
1
Name:
SHIRLEY, Bret, A., Chiron Corporation
Legal Form:
Address:
2
Name:
CHOE, Minna, Chiron Corporation
Legal Form:
Address:
3
Name:
TELLERS, Melanie, Chiron Corporation
Legal Form:
Address:
4
Name:
BABUKA, Susan, Chiron Corporation
Legal Form:
Address:
5
Name:
CHEN, Bao-Lu, Novartis Vaccines and Diagnostics, Inc.
Legal Form:
Address:
6
Name:
HORA, Maninder, Novartis Vaccines and Diagnostics, Inc.
Legal Form:
Address:
Priority
1
Priority patent number:
35397
Priority date:
25/10/2001
Priority country:
United States (US)
2
Priority patent number:
330404
Priority date:
18/10/2001
Priority country:
United States (US)
3
Priority patent number:
282614
Priority date:
09/04/2001
Priority country:
United States (US)
Classification
Main IPC class:
A61K 38/21 ;
IPC or IDT classification:
A61K 9/08 ;
A61K 47/12 ;
A61K 47/16 ;
Publication
Bulletin
1
Bulletin heading:
EP2
Journal edition number:
2012/02
Publication date:
29/02/2012
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed
2
Bulletin heading:
CO
Journal edition number:
2018/01
Publication date:
22/02/2018
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders
3
Bulletin heading:
CO
Journal edition number:
2018/01
Publication date:
22/02/2018
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders
4
Bulletin heading:
CO
Journal edition number:
2018/04
Publication date:
14/03/2018
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders
5
Bulletin heading:
VRV
Journal edition number:
2021/20
Publication date:
17/11/2021
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)
Deed
Change of owner(s)
Change Kind / Decision Type:
Other
Deed number:
RC2017100547A
Registration date:
06/12/2017
License effective date:
License expiration date:
Scope of license:
Deed filer:
CHAILLOT Geneviève
Bulletin edition number:
Text:
Country code:
Updated license number:
Terminated license number:
Removed pledgee
Name:
Address:
Changed pledgee
Name:
Address:
Removed usufructuary
Name:
Address:
Added usufructuary
Name:
Address:
Changed usufructuary
Name:
Address:
Change of owner(s)
Change Kind / Decision Type:
Assignment
Deed number:
RC2017100547E
Registration date:
06/12/2017
License effective date:
License expiration date:
Scope of license:
Deed filer:
CHAILLOT Geneviève
Bulletin edition number:
Text:
Country code:
Updated license number:
Terminated license number:
Removed pledgee
Name:
Address:
Changed pledgee
Name:
Address:
Removed usufructuary
Name:
Address:
Added usufructuary
Name:
Address:
Changed usufructuary
Name:
Address:
Change of owner(s)
Change Kind / Decision Type:
Change of owner(s) name
Deed number:
RC2018000107A
Registration date:
15/02/2018
License effective date:
License expiration date:
Scope of license:
Deed filer:
CABINET CHAILLOT
Bulletin edition number:
Text:
CORRECTION
Country code:
Updated license number:
Terminated license number:
Removed pledgee
Name:
Address:
Changed pledgee
Name:
Address:
Removed usufructuary
Name:
Address:
Added usufructuary
Name:
Address:
Changed usufructuary
Name:
Address:
Annual fee
Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
22/09/2020
Last annual fee paid number:
20
Last annual fee paid amount:
600 Euro
Payer:
CLARIVATE ANALYTICS (MASTER DATA CENTER)